Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

1.28
-0.1200-8.57%
Post-market: 1.310.0300+2.34%19:56 EDT
Volume:914.58K
Turnover:1.21M
Market Cap:207.33M
PE:-0.84
High:1.43
Open:1.42
Low:1.27
Close:1.40
Loading ...

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

MT Newswires Live
·
10 Mar

Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
08 Mar

William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold

TIPRANKS
·
08 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed

Reuters
·
08 Mar

JNJ Halts Development of Depression Drug Over Efficacy Concerns

Zacks
·
08 Mar

Neumora Therapeutics Shares Fall 13.8% After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS
·
07 Mar

BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug

Reuters
·
07 Mar

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'

Benzinga
·
07 Mar

Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS
·
07 Mar

Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
07 Mar

BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback

Reuters
·
07 Mar

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

MT Newswires Live
·
07 Mar

Neumora Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $2 From $6

THOMSON REUTERS
·
07 Mar

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

GlobeNewswire
·
04 Mar

Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays

TIPRANKS
·
04 Mar

Neumora Therapeutics Price Target Maintained With a $5.00/Share by Needham

Dow Jones
·
04 Mar